Polycythemia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:
*The prevalence of polycythemia vera in the 7 MM countries was 283,442 in 2017.
*The prevalence of polycythemia vera in the 7 MM countries was 283,442 in 2017.
*Prevalence of polycythemia vera was the highest in the US in 2017 at 157,290, out of which 62,916 cases were asymptomatic and 94,374 were symptomatic. <ref name="urlPolycythemia Vera (PV): Trends, Epidemiology (2017-2030), KOL Views and Unmet Needs">{{cite web |url=https://www.globenewswire.com/news-release/2020/07/15/2062391/0/en/Polycythemia-Vera-PV-Trends-Epidemiology-2017-2030-KOL-Views-and-Unmet-Needs.html |title=Polycythemia Vera (PV): Trends, Epidemiology (2017-2030), KOL Views and Unmet Needs |format= |work= |accessdate=}}</ref>
*Prevalence of polycythemia vera was the highest in the US in 2017 at 157,290, out of which 62,916 cases were asymptomatic and 94,374 were symptomatic. <ref name="urlPolycythemia Vera (PV): Trends, Epidemiology (2017-2030), KOL Views and Unmet Needs">{{cite web |url=https://www.globenewswire.com/news-release/2020/07/15/2062391/0/en/Polycythemia-Vera-PV-Trends-Epidemiology-2017-2030-KOL-Views-and-Unmet-Needs.html |title=Polycythemia Vera (PV): Trends, Epidemiology (2017-2030), KOL Views and Unmet Needs |format= |work= |accessdate=}}</ref>
 
*22 cases per 100,000 people. <ref name="urlwww.lls.org">{{cite web |url=https://www.lls.org/sites/default/files/file_assets/FS13_PolycythemiaVera_FactSheet_final5.1.15.pdf |title=www.lls.org |format= |work= |accessdate=}}</ref>


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===

Revision as of 02:38, 9 December 2020

Polycythemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycythemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polycythemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycythemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycythemia epidemiology and demographics

CDC on Polycythemia epidemiology and demographics

Polycythemia epidemiology and demographics in the news

Blogs on Polycythemia epidemiology and demographics

Directions to Hospitals Treating Polycythemia

Risk calculators and risk factors for Polycythemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Debduti Mukhopadhyay, M.B.B.S[2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence of polycythemia vera is approximately 1.9 per 100,000 individuals in the United States.
  • Taking into account all races and ethnicities, the incidence is approximately 2.8 per 100,000 males and 1.3 per 100,000 in females. [1]

Prevalence

  • The prevalence of polycythemia vera in the 7 MM countries was 283,442 in 2017.
  • Prevalence of polycythemia vera was the highest in the US in 2017 at 157,290, out of which 62,916 cases were asymptomatic and 94,374 were symptomatic. [2]
  • 22 cases per 100,000 people. [1]

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • It has been noted that PV is more common in the age group >75. [2]
  • Median age of diagnosis is 60. [3]
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • Jews of Eastern European descent have a higher number of cases as compared to other Europeans or Asians. [1]

Gender

  • Generally, there is no sex predeliction.[3]
  • In the analysis for the 7 MM countries, the percentage of prevalent males was higher than prevalent females. [2]

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

  1. 1.0 1.1 1.2 "www.lls.org" (PDF).
  2. 2.0 2.1 2.2 "Polycythemia Vera (PV): Trends, Epidemiology (2017-2030), KOL Views and Unmet Needs".
  3. 3.0 3.1 Lu X, Chang R. PMID 32491592 Check |pmid= value (help). Missing or empty |title= (help)

Template:WS Template:WH